About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Posterior Segment Eye Disorders Market Size, Top Share to 2031
Posterior Segment Eye Disorders Market

Posterior Segment Eye Disorders Market Size, Share & Trends Analysis Report By Product (Drugs, Devices), By Application (Macular Degeneration, Glaucoma, Diabetic Retinopathy) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI3642DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Posterior Segment Eye Disorders Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Drugs
        1. By Value
      3. Devices
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Macular Degeneration
        1. By Value
      3. Glaucoma
        1. By Value
      4. Diabetic Retinopathy
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Drugs
        1. By Value
      3. Devices
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Macular Degeneration
        1. By Value
      3. Glaucoma
        1. By Value
      4. Diabetic Retinopathy
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Drugs
          1. By Value
        3. Devices
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Macular Degeneration
          1. By Value
        3. Glaucoma
          1. By Value
        4. Diabetic Retinopathy
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Drugs
        1. By Value
      3. Devices
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Macular Degeneration
        1. By Value
      3. Glaucoma
        1. By Value
      4. Diabetic Retinopathy
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Drugs
          1. By Value
        3. Devices
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Macular Degeneration
          1. By Value
        3. Glaucoma
          1. By Value
        4. Diabetic Retinopathy
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Drugs
        1. By Value
      3. Devices
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Macular Degeneration
        1. By Value
      3. Glaucoma
        1. By Value
      4. Diabetic Retinopathy
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Drugs
          1. By Value
        3. Devices
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Macular Degeneration
          1. By Value
        3. Glaucoma
          1. By Value
        4. Diabetic Retinopathy
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Drugs
        1. By Value
      3. Devices
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Macular Degeneration
        1. By Value
      3. Glaucoma
        1. By Value
      4. Diabetic Retinopathy
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Drugs
          1. By Value
        3. Devices
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Macular Degeneration
          1. By Value
        3. Glaucoma
          1. By Value
        4. Diabetic Retinopathy
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Drugs
        1. By Value
      3. Devices
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Macular Degeneration
        1. By Value
      3. Glaucoma
        1. By Value
      4. Diabetic Retinopathy
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Drugs
          1. By Value
        3. Devices
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Macular Degeneration
          1. By Value
        3. Glaucoma
          1. By Value
        4. Diabetic Retinopathy
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Posterior Segment Eye Disorders Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Alcon Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. AbbVie Inc. (Allergen PLC)
    3. Bausch Health Companies Inc.
    4. F Hoffmann-La Roche
    5. Merck and Co. Inc.
    6. Novartis AG
    7. Santen Pharmaceuticals
    8. Rainbow Medical Ltd (Nano Retina)
    9. Regeneron Pharmaceuticals Inc.
    10. Second Sight Medical Products Inc.
    11. Aerie Pharmaceuticals
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
X-Ray Inspection System Market Size The global x-ray inspection system market size was valued at USD 834.65 million in 2024 and is expected to grow from USD 889.74 million in 2025 to reach USD 1483.61 million by 2033, growin
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.